MDIHX
Price
$29.88
Change
+$0.19 (+0.64%)
Updated
Jun 2 closing price
Net Assets
44.56B
NIEYX
Price
$17.80
Change
+$0.08 (+0.45%)
Updated
Jun 2 closing price
Net Assets
332.3M
Interact to see
Advertisement

MDIHX vs NIEYX

Header iconMDIHX vs NIEYX Comparison
Open Charts MDIHX vs NIEYXBanner chart's image
MDIHX vs NIEYX Comparison Chart in %
View a ticker or compare two or three
VS
MDIHX vs. NIEYX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDIHX is a Hold and NIEYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 44.6B vs. NIEYX (332M). NIEYX pays higher dividends than MDIHX: NIEYX (2.45) vs MDIHX (1.85). MDIHX was incepted earlier than NIEYX: MDIHX (21 years) vs NIEYX (13 years). MDIHX (1.10) is less costly to investors than NIEYX (0.93). NIEYX is a more actively managed with annual turnover of: 230.46 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than NIEYX: MDIHX (0) vs NIEYX (1000000). MDIHX annual gain was more profitable for investors over the last year : 17.73 vs. NIEYX (2.17). MDIHX return over 5 years is better than : 27.94 vs. NIEYX (-24.35).
MDIHXNIEYXMDIHX / NIEYX
Total Expense Ratio1.080.79137%
Annual Report Gross Expense Ratio1.100.93118%
Fund Existence21 years13 years-
Gain YTD9.4366.235151%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets44.6B332M13,434%
Annual Yield % from dividends1.852.4576%
Returns for 1 year17.732.17818%
Returns for 3 years46.99-10.66-441%
Returns for 5 years27.94-24.35-115%
Returns for 10 years123.068.811,397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOB37.810.48
+1.29%
Live Oak Bancshares
PKBK31.070.36
+1.19%
Parke Bancorp
IPCXU10.64N/A
N/A
Inflection Point Acquisition Corp
STN74.84-1.53
-2.00%
Stantec
ESLA1.08-0.04
-3.57%
Estrella Immunopharma